Views & Analysis Health data security: report’s implications for pharma Data security issues that could have an impact on the pharma industry.
Views & Analysis Healthcare’s hype cycle: which technologies will stay the co... Where should pharma invest to remain at the forefront of healthcare?
Views & Analysis Better clinical trial management Streamlining processes can improve clinical trial management, in terms of speed, quality and better collaboration.
Views & Analysis The evolving role of clinical trial data sharing Clinical trial data sharing has massive potential for catalysing scientific innovation.
Views & Analysis Healthcare evidence development: guilty until proven innocen... Pharma must prepare its case meticulously to support its new drug applications.
Views & Analysis Better customer engagement: Is your data letting you down? The pressure is on for better quality, more granular customer data.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
